Literature DB >> 8587043

Characterization of erythropoietin dimerization.

A M DePaolis1, J V Advani, B G Sharma.   

Abstract

Recombinant human erythropoietin (rHuEPO) is a monomeric glycoprotein hormone when stored under refrigeration. Higher temperatures and various formulation conditions have shown the monomer to partially dimerize followed by aggregation to higher molecular weight species. To protect the product against aggregation, it is critical to understand this dimerization mechanism. The formation of the dimer was analyzed by matrix-assisted laser desorption time-of-flight mass spectrometry, endoproteinase LysC mapping, and N-terminal sequencing. The dimer was shown to have an average molecular mass of 53.5 kDa vs 27.8 kDa for the monomer. The dimer to monomer ratio of 1.9 instead of 2 seemed to be caused by some loss of sialic acids during the purification. The LysC map of the dimer also showed two new peptide peaks not present in the monomer. The sequencing of the new peptides revealed the presence of two types of EPO dimers. The data indicate the dimerization mechanism to involve an initial reduction of the Cys7-Cys161 disulfide bond and subsequent random reoxidation of the free thiols across two EPO molecules. The absence of free thiols in the dimer was confirmed by a fluorescent thiol probe. The higher molecular weight aggregation followed from random intermolecular reoxidation of Cys7 and Cys161.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587043     DOI: 10.1002/jps.2600841105

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.

Authors:  Annabelle P Villalobos; Srinivas R Gunturi; George A Heavner
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

2.  Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin.

Authors:  Stefanie Strobach; Renate Kunert; Johannes Stadlmann; Paul Messner; Eva Sevcsik; Gabriele Lhota; Hermann Katinger; Karola Vorauer-Uhl
Journal:  J Liposome Res       Date:  2010-03       Impact factor: 3.648

3.  Zinc-dependent multimerization of mutant calreticulin is required for MPL binding and MPN pathogenesis.

Authors:  Jeanne F Rivera; April J Baral; Fatima Nadat; Grace Boyd; Rachael Smyth; Hershna Patel; Emma L Burman; Ghadah Alameer; Sally A Boxall; Brian R Jackson; E Joanna Baxter; Peter Laslo; Anthony R Green; David G Kent; Ann Mullally; Edwin Chen
Journal:  Blood Adv       Date:  2021-04-13

4.  Development of a stable chemically cross-linked erythropoietin dimer for use in the quality control of erythropoietin therapeutic products.

Authors:  Paul Matejtschuk; Chinwe Duru; Kiran P Malik; Adrian F Bristow; Angele Costanzo; Chris J Burns
Journal:  Anal Bioanal Chem       Date:  2019-04-10       Impact factor: 4.142

5.  A Reference Standard for Analytical Testing of Erythropoietin.

Authors:  Huiping Tu; Kevin Carrick; Rebecca Potts; Mark Hasselberg; Mark Verdecia; Chris Burns; Ben Cowper; Fouad Atouf
Journal:  Pharm Res       Date:  2022-03-15       Impact factor: 4.200

6.  Cell-free protein synthesis as a novel tool for directed glycoengineering of active erythropoietin.

Authors:  Anne Zemella; Lena Thoring; Christian Hoffmeister; Mária Šamalíková; Patricia Ehren; Doreen A Wüstenhagen; Stefan Kubick
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.